The Best of Forum series features encore webinar presentations of the top-rated sessions from the 24th Annual EHS Management Forum in Denver, Colorado. These interactive presentations are peer-led case studies from leading companies that represent the latest in EHS and sustainability management. If you missed the Forum, this series is an effective way to benchmark your program, ask questions, and share the Forum experience with your team.
Risk Management Approaches to Safety Performance Improvements
Thursday December 8, 2016
1:00 -2:30 p.m.
Purchase this webinar
Cost: $99 for Members, $189 for Non-Members
For leading companies, safety management isn’t just a collection of programs. It is embedded in the company culture, touching each and every employee and influencing behavior on and off the job. Learn how to develop a safety strategy and measure success, and will also feature a variety of tools and systematic approaches to reduce safety risks, drive down injury rates, engage employees and extend safety beyond your company walls.
This session will defy traditional safety thinking and showcase new tools and approaches to drive continuous safety performance improvements. You'll hear how organizations have prioritized risk; how they've focused on high risk areas through Serious Injury and Fatality (SIF) prevention; and how they've managed risk by looking at human and organizational performance.
- Sulaiman Hamidi, Director, Sustainability & Product Stewardship; Allergan plc
- Dave Eherts, Vice President, EHS; Allergan plc
- Monty Gartin, Business Unit Health and Safety Advisor; Cargill Inc.
Dr. Eherts joined Allergan (then Actavis) Pharmaceuticals in March of 2014 as Vice President of Global EHS. Allergan is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. Allergan is a leader in a new segment called “Growth Pharma” and Forbes has ranked Actavis #1 in its list of the top 17 global large cap ($50+ billion market capitalization) pharmaceutical companies.
Prior to Allergan, David has worked over 30 years in the fields of Safety and EHS starting as a toxicologist in Pre-Clinical Drug Safety Assessment at Merck. He moved to EHS and has held positions of increasing responsibility at Merck, Sanofi-Aventis, Purdue Pharmaceuticals and just prior to Allergan, he led Aviation and Product Safety at Sikorsky Aircraft as their Vice President and Chief Safety Officer. His experience and expertise span aviation, environmental toxicology, occupational health, potent compound control and management systems in the aerospace, healthcare and pharmaceutical industries.
Dave holds Bachelor’s degrees in Chemistry and Biology and a Masters and PhD in Environmental Toxicology from Drexel University. In his spare time, he's an adjunct professor at New York Medical College and at Tulane University where he teaches courses in EHS Management, Environmental Toxicology, Industrial Hygiene and Occupational Health.
With more than 25 years of EH&S experience in multiple industries, Monty has learned how to lead the way to EH&S excellence and how to build strong partnerships to achieve injury reduction results and build trust.
Monty has focused on an understanding of the science and psychology of safety and that it must be coupled with sustained regulatory compliance in order to build strong leaders at every level. Prior to Cargill, Monty work in petrochemical and refining with ExxonMobil.